Angela M. Stupi, M.D.September 29, 2022

FDA 483 - Angela M. Stupi, M.D. - September 29, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Angela M. Stupi, M.D.

Record Details

An FDA inspection of Angela M. Stupi, M.D. revealed significant deviations in the conduct of clinical investigations. The firm failed to adhere to investigational plans and protocols regarding subject eligibility, screening, safety assessments, and study drug administration. Additionally, the firm did not maintain adequate and accurate case histories, leading to inaccurate reporting to the sponsor and missing documentation.

Company: Angela M. Stupi, M.D.
Inspection Date: September 29, 2022
Product Type: Drugs
Office: Philadelphia District Office
Person: Cynthia L. Rakestraw

Open in Dashboard

ID · 1a29b7a6-3323-4b18-b8b0-5352623097a6